We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Thermo Fisher Scientific Showcases Product Portfolio at Lab Trade Show

By LabMedica International staff writers
Posted on 01 Aug 2018
Print article
Image: One model from the new series of TSG compact refrigerators (Photo courtesy of Thermo Fisher Scientific).
Image: One model from the new series of TSG compact refrigerators (Photo courtesy of Thermo Fisher Scientific).
Thermo Fisher Scientific Inc. (Waltham, MA, USA) showcased innovations for research and clinical labs and also launched a new series of compact refrigerators at the 2018 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo held July 29 – August 2 in Chicago, USA.

At AACC 2018, Thermo Fisher displayed its range of LC-MS instruments, including the fully automated Cascadion SM Clinical Analyzer, Prelude LX-4 MD HPLC, and Endura MD Mass Spectrometer. Thermo Fisher’s lab solutions portfolio showcased at this year’s AACC included the recently CE-marked Phadia 200 instrument which requires less than six square feet of lab space and can run up to 700 different ImmunoCAP and EliA quantitative tests, including the recently cleared peanut allergen component ImmunoCAP Ara h6. Thermo Fisher also showcased its new B·R·A·H·M·S KRYPTOR GOLD immunoassay analyzer, which features increased capacity and has been developed for optimal automation, efficiency and precision.

Thermo Fisher showcased its Ion Torrent Oncomine solutions, including the Oncomine Dx Target Test, the first FDA-approved companion diagnostic for non-small cell lung cancer. The company also demonstrated its Ion GeneStudio S5 Prime system, as well as other oncology research assays designed for studies in blood-based cancers, liquid biopsy, childhood cancers and immuno-oncology. In addition, Thermo Fisher featured new compounds for antimicrobial susceptibility testing: delafloxacin and meropenem/vaborbactam. Also on display at the event were the recently announced Thermo Scientific B·R·A·H·M·S PCT direct point-of-care assay for procalcitonin (PCT) measurement in acute care settings and its novel range of ChromaCare flush solutions and ultrapure solvents for ultrahigh-performance LC-MS systems.

"Clinical customers and translational researchers demand analytical platforms that support higher throughput, accuracy and scalability," said Patrick Durbin, senior vice president and president of specialty diagnostics for Thermo Fisher Scientific. "The common goal is actionable data that's delivered with confidence, and we're highlighting our portfolio of leading products at AACC to support their needs, from research to the clinic."

At this year’s AACC, Thermo Fisher launched the new series of TSG compact refrigerators for clinical laboratories and patient care facilities requiring secure and energy-efficient storage of vaccines, medicines, lab kits and breast milk, all in a quiet unit with a small footprint. The new refrigerators have been designed to provide uninterrupted temperature stability and cleanroom-compatible readiness for reliable materials storage. They operate at a sound level of less than 35 dbA and have ENERGY STAR-rated performance, consuming significantly less energy than similar models to meet increasing demands for sustainability and reduced operating costs.

"Maintaining optimal cold storage conditions is of utmost importance in clinical settings to preserve the viability of stored materials, as is the need to maximize efficiencies by locating vaccines, medicines and lab kits close to their point of use," said Alex Esmon, senior product manager, cold storage, laboratory equipment, Thermo Fisher Scientific. "With this in mind, we have introduced the new series of high-performing refrigerators to offer our clinical customers confidence that their valuable materials are fully protected at all times. The solid state technology used in the TSG Series allows for minimal impact on the clinical environment through reduced operational noise and heat output, while the systems' small size maximizes working space."

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more